In the present study, our in vitro data as well as our animal and clinical results demonstrated that TGF-β1 was upregulated in the mouse ovary and follicular fluid of patients with OHSS, and this upregulation subsequently contributes to increased VEGF expression. This evidence concerns the gene VEGFA and ovarian hyperstimulation syndrome.